A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers.
Clinical trial NCT05457270 · COMPLETED
Trial details
- NCT number
- NCT05457270
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-11
- Primary completion
- 2022-10-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.